OMER · Omeros Corp
$17.19
-0.16 (-0.92%)
At close · Aug 14
Market Cap
$1.24B
Shares
72.39M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$73.81M
-34%
FY2020
Net Income
-$3.35M
+97.9%
FY2025
Gross Margin
98.78%
-0.4pp
FY2020
Operating Margin
-212.59%
-82pp
FY2020
Diluted EPS
-$0.05
+98.1%
FY2025
Operating Cash Flow
-$116.09M
+22%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | $73.81M | $111.81M | $29.87M | $64.83M | $41.62M | $13.51M | $539K | $1.6M | $6.02M | $4.52M | $2.11M | $1.44M | |
| — | — | — | — | — | — | $902K | $865K | $512K | $1.08M | $1.41M | $1.04M | $0 | $0 | — | — | — | — | |
| — | — | — | — | — | — | $72.91M | $110.94M | $29.36M | $63.75M | $40.21M | $12.47M | $539K | $1.6M | — | — | — | — | |
| — | — | — | — | — | — | 98.78% | 99.23% | 98.29% | 98.34% | 96.61% | 92.29% | 100% | 100% | — | — | — | — | |
| $62.6M | $81.3M | $119.52M | $114.87M | $112.72M | $118.78M | $107.61M | $106.32M | $89.86M | $55.6M | $50.7M | $48.38M | $47.95M | $36.3M | $31.92M | $23.72M | $23.47M | $16.93M | |
| $48.15M | — | — | — | $50.67M | $54.84M | $49.31M | $39.71M | $51.72M | $52.04M | $43.78M | $35.33M | $22.6M | $15.82M | $10.99M | $8.22M | $8.75M | $5.27M | |
| $47.26M | $41.5M | $47.43M | $49.66M | $50.67M | $54.84M | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $964K | $950K | $920K | $952K | $1.39M | $1.62M | $1.79M | $962K | $551K | $300K | $209K | $317K | $302K | $320K | $435K | $472K | $451K | |
| $153.83M | — | — | — | — | — | — | — | $142.09M | $108.72M | $95.89M | $84.75M | $70.55M | $52.12M | $42.91M | $31.93M | $32.21M | $22.2M | |
| $111.24M | $122.8M | $166.95M | $164.53M | $163.39M | $173.62M | $156.92M | $146.04M | $142.09M | $108.72M | — | — | — | — | — | — | — | — | |
| -$72.82M | -$122.8M | -$166.95M | -$164.53M | -$163.39M | -$173.62M | -$156.92M | -$146.04M | -$112.22M | -$43.9M | -$54.28M | -$71.24M | -$70.01M | -$50.52M | -$36.89M | -$27.41M | -$30.11M | -$20.76M | |
| — | — | — | — | — | — | -212.59% | -130.62% | -375.73% | -67.71% | -130.42% | -527.34% | -12988.5% | -3157.25% | -612.5% | -605.88% | -1430.21% | -1437.53% | |
| — | -$121.83M | -$166M | -$163.61M | -$162.44M | -$172.23M | -$155.3M | -$144.25M | -$111.26M | -$43.34M | -$53.98M | -$71.03M | -$69.69M | -$50.21M | -$36.57M | -$26.98M | -$29.63M | -$20.31M | |
| $8.85M | -$960K | $24.68M | $30.84M | $22.7M | $19.67M | $26.75M | $22.66M | $16.25M | $11.03M | $7.82M | $3.57M | $3.47M | $2.37M | $1.73M | $1.88M | $1.54M | $2.2M | |
| — | $2.3M | $8.4M | $14.7M | $2.2M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $2.15M | — | — | — | — | $1.74M | $654K | $1.55M | $1.78M | $1.44M | $945K | — | -$207K | $574K | $130K | $697K | $2.52M | $1.66M | |
| — | -$2.8M | -$180.32M | -$174.92M | -$182.03M | -$191.55M | -$196.39M | -$167.14M | -$139.69M | -$53.48M | -$66.75M | — | — | — | — | — | — | — | |
| — | $2.01M | $2.31M | $0 | $0 | $0 | -$23.26M | -$19.77M | -$12.93M | $0 | $0 | — | — | — | — | — | — | — | |
| $124.83M | -$3.35M | -$156.82M | -$117.81M | $47.42M | $194.24M | -$138.06M | -$84.49M | -$126.76M | -$53.48M | -$66.75M | -$75.1M | -$73.67M | -$39.8M | -$38.44M | -$28.55M | -$29.25M | -$21.09M | |
| — | — | — | — | — | — | -187.04% | -75.57% | -424.39% | -82.5% | -160.38% | -555.9% | -13668.46% | -2487.25% | -638.39% | -630.99% | -1389.6% | -1460.46% | |
| -$123.66M | — | — | — | — | — | -$138.06M | -$84.49M | -$126.76M | -$53.48M | -$66.75M | -$75.1M | -$73.67M | -$39.8M | -$38.44M | -$28.55M | -$29.29M | -$20.95M | |
| USD/shares | — | -$0.05 | -$2.70 | -$1.88 | $0.76 | $3.12 | -$2.41 | -$1.71 | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$0.05 | -$2.70 | -$1.88 | $0.76 | $3.12 | -$2.41 | -$1.71 | — | — | — | — | — | — | — | — | — | — |
| shares | — | 63.51M | 58.17M | 62.74M | 62.74M | 62.34M | 57.18M | 49.52M | 48.58M | 45.54M | 40.45M | 37.56M | 33.23M | 28.56M | 24.16M | 22.21M | 21.42M | — |
| shares | — | — | — | — | 62.74M | 62.34M | 57.18M | 49.52M | 48.58M | 45.54M | 40.45M | 37.56M | 33.23M | 28.56M | 24.16M | 22.21M | 21.42M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2025: $16.51M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 7.30×
EV/EBIT
—
Peer median 22.07×
P/E (TTM)
—
Peer median 16.89×
Peer medians compare against the 297 similar-size Biotechnology companies (of 545 listed).
Valuation over time computed as of each quarter's filing date
Key facts
CIK
1285819
CUSIP
682143102
13F (30d)
174 filings
167 filers
Visit website
Investor relations